# A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

> **NCT02898727** · NA · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 25 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **OTHER:** Local Therapy

## Key facts

- **NCT ID:** NCT02898727
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-20
- **Primary completion:** 2021-07-22
- **Final completion:** 2021-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02898727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02898727, "A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02898727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*